Cancer Research SABCS  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, J.
Right arrow Articles by Schweigerer, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, J.
Right arrow Articles by Schweigerer, L.
[Cancer Research 66, 5314-5321, May 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Keratoepithelin Suppresses the Progression of Experimental Human Neuroblastomas

Jürgen Becker1, Bernhard Erdlenbruch1, Ievgeniia Noskova1, Alexander Schramm2, Monique Aumailley3, Daniel F. Schorderet4 and Lothar Schweigerer1

1 Abteilung Pädiatrie I, Zentrum Kinderheilkunde und Jugendmedizin, Klinikum der Georg-August-Universität Göttingen, Göttingen, Germany; 2 Abteilung Hämatologie, Onkologie und Endokrinologie, Universitätsklinikum Essen-Duisburg, Essen, Germany; 3 Institut für Biochemie II und Zentrum für Molekulare Medizin Köln, Universität zu Köln, Köln, Germany; and 4 Institut de Recherche en Ophtalmologie, Department of Ophthalmology, University of Lausanne, Sion, Switzerland

Requests for reprints: Lothar Schweigerer, Abteilung Pädiatrie I, Zentrum Kinderheilkunde und Jugendmedizin, Klinikum der Georg-August-Universität Göttingen, D-37075 Göttingen, Germany. Phone: 49-551-39-6200; Fax: 49-551-39-6231; E-mail: Lothar.Schweigerer{at}med.uni-goettingen.de.

Neuroblastoma is the most common extracranial childhood tumor. High expression of activin A is associated with a favorable prognosis, but the contributing mechanisms have remained unclear. Our previous demonstration of the activin A–mediated up-regulation of keratoepithelin led to the consideration that keratoepithelin could modulate neuroblastoma growth and/or progression. We report here that enhanced keratoepithelin expression in human neuroblastoma cells suppresses neuroblastoma cell cohesion and adhesion to various extracellular matrix proteins and that it inhibits neuroblastoma cell proliferation and invasion in vitro and in vivo. Using microarray analysis, we identified several keratoepithelin-regulated genes that may contribute to these biological changes. Together with the observation that keratoepithelin is expressed in human neuroblastomas in vivo, our data suggest that keratoepithelin could play a beneficial role in neuroblastoma development and/or progression. (Cancer Res 2006; 66(10): 5314-21)




This article has been cited by other articles:


Home page
IOVSHome page
L. Shelton and J. A. Summers Rada
Inhibition of Human Scleral Fibroblast Cell Attachment to Collagen Type I by TGFBIp
Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3542 - 3552.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.